Latest updates for Biosneds Apigensol
Fresh curated links around BioSNEDS ApigenSol are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Apogee Therapeutics: Targeting Atopic Dermatitis
- Precigen (PGEN) Secures FDA Orphan Drug Exclusivity for PAPZIMEOS
- Ingredion acquires Benicaros that supports immune health at low daily dosage
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Precigen (PGEN) Secures FDA Orphan Drug Exclusivity for PAPZIMEOS
Ingredion acquires Benicaros that supports immune health at low daily dosage
Ingredion Incorporated NYSE INGR a leading global provider of ingredient solutions for the food beverage and industrial markets announced the acquisition of Benicaros a patented pr...
Sanofi, Pangaea ink AI partnership deal to detect underdiagnosed genetic disease
French biopharma Sanofi inked a partnership deal with Pangaea Data to use its AI platform that helps detect Alpha-1 Antitrypsin Deficiency (AATD) that will be distributed to select...
AbbVie to Acquire Apogee Therapeutics for $10.9B
Apogee’s lead candidate zumilokibart, an IL-13 inhibitor also called APG777, is a long-acting treatment that, according to the company, holds “pipeline-in-a-product potential” beca...
Peptistar Began Operation of the Asahi Kasei FO-MD System at Manufacturing Scale
FO utilizes an osmotic pressure difference across a membrane to remove water from liquids, achieving highly concentrated API solutions under mild conditions. MD leverages a vapor p...
Skape Bio Unlocks Generalizable GPCR Drugs Using AI Protein Design
David Baker’s latest company is making medicines for a huge protein family once deemed undruggable. A new study generated miniproteins that target GPCRs across a diversity of recep...
Major Biopharmaceutical Company Files First-in-Human Trial Supported by PAK BioSolutions GMP Purification System
A major biopharmaceutical company has filed a First-in-Human (FIH) clinical trial application with drug product manufactured using the PAK BioSolutions system. The milestone demons...
Agenus surges on study pivot; Apnimed lines up an IPO
Agenus is financially abandoning an ongoing study in late-line colorectal cancer. Elsewhere, an ebola vaccine began human testing and an important Bristol Myers medicine got an FDA...
NOW, LeafWorks Advance Identity Verification Testing for Botanical Ingredients
The platform was developed to address limitations of earlier DNA barcoding methods by using species-targeted genomic approaches, authenticated reference materials, and analytical s...
<![CDATA[The Only AI Simulation Built for Life Sciences ]]>
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.